CVDs have a significant impact on public health and are the leading cause of death and disability worldwide
whether hormonal, metabolic, or lifestyle-related
For example, the SELECT trial clearly demonstrated that semaglutide significantly reduces the risk of major adverse cardiovascular events (MACE), leading to FDA approval for lowering the risk of cardiovascular death, myocardial infarction, or stroke in overweight or obese adults with established cardiovascular disease ( ) for reducing the risk of kidney failure and disease progression in patients with diabetes and chronic kidney disease (CKD), making it the first GLP-1 agent indicated for the treatment of CKD ( In parallel with these clinical advances, the growth of academic output has been striking
Everything about the presentation says they take handling seriously
Registered Dietitian, Rita Faycurry, RD , shares a few tips: Prioritize protein at every meal to preserve muscle mass and control hunger
GIP promotes fatty acid synthesis and glucose uptake in adipose tissue with the development of obesity (Getty-Kaushik et al
